Biotech · Private company
Abcentra
Track this companyFree. Adds Abcentra to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- OrticumabPhase 2 · Acute Coronary SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- OrticumabPhase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Focused Orticumab Research for Treating Inflammation in Coronary ArteriesPHASE2 · RECRUITING · started Aug 11, 2025ClinicalTrials.gov NCT06927739 · fetched Nov 12, 2026
- A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk FactorsPHASE2 · COMPLETED · started Jun 30, 2021ClinicalTrials.gov NCT04776629 · fetched Nov 12, 2026